Question 1

Does DnB Asset Management own ABCL stock?

Accepted Answer

Yes. As of its Q2 2026 13F, DnB Asset Management holds 677,479 shares of ABCL (Abcellera Biologics), worth $5.3M.

Question 2

How many shares of ABCL does DnB Asset Management own?

Accepted Answer

As of its Q2 2026 13F, DnB Asset Management holds 677,479 shares of ABCL (Abcellera Biologics).

Question 3

What is DnB Asset Management's ABCL position worth?

Accepted Answer

As of its Q2 2026 13F, DnB Asset Management's ABCL position is worth $5.3M.

Question 4

Is DnB Asset Management buying or selling ABCL?

Accepted Answer

In Q2 2026, DnB Asset Management opened a new ABCL position of 677,479 shares.

Question 5

When did DnB Asset Management first buy ABCL?

Accepted Answer

DnB Asset Management first reported ABCL in its Q3 2024 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	677,479	-	$5.3M	0.0%	$7.85	37
2025-Q4	Exited	0	-100.0%	$0	0.0%	$3.45	0
2025-Q3	New	656,208	-	$3.3M	0.0%	$4.87	37
2025-Q1	Exited	0	-100.0%	$0	0.0%	$2.31	0
2024-Q4	Increased	305,579	+424.7%	$895,346	0.0%	$2.82	40
2024-Q3	New	58,237	-	$151,416	0.0%	$2.61	31

ABCL6 quarters

ABCL
6 quarters